| Akela Pharma Reports Results for Fourth Quarter and Fiscal 2008 (CNW Group via Yahoo! Finance) |
|
|
Akela Pharma Inc. , a drug development company focused on developing an inhaled fentanyl product for breakthrough cancer pain and a growth hormone releasing hormone for chronic renal disease, today announced its financial results for the three and twelve month period ended December 31, 2008. |